New Prognostic Tool for Immune Checkpoint Inhibitor-treated NSCLC

In this MEDtalk, Marcus Skribek, Karolinska Institute in Stockholm, Sweden, presents the rationale, methods, and key results of the study on the BLIP score and offers his perspective on why it may be useful as a prognostic tool in real-world practice.